EMA recommends next season's COVID vaccines should target XFG variant

The European Medicines Agency said COVID-19 vaccines for the 2026-27 vaccination campaign in Europe should preferably be updated to target the XFG variant. The guidance is a regulatory/public health recommendation rather than a market-moving policy change, with limited immediate financial impact.

Analysis

The European Medicines Agency said COVID-19 vaccines for the 2026-27 vaccination campaign in Europe should preferably be updated to target the XFG variant. The guidance is a regulatory/public health recommendation rather than a market-moving policy change, with limited immediate financial impact.